Cannabis Clinical Trials UK – Current Research

Medical Cannabis Clinical Trials in the UK: A Comprehensive Overview

The landscape of medical cannabis research in the United Kingdom has undergone significant transformation since the rescheduling of cannabis-based medicinal products in November 2018. This shift has enabled an increasing number of rigorous clinical trials to investigate the therapeutic potential of cannabis for various medical conditions. The UK now hosts several large-scale, government-approved trials that aim to generate robust evidence to inform clinical practice and policy.

The Current Trial Landscape

Medical cannabis research in the UK is primarily coordinated through three major organisations that have become instrumental in advancing evidence-based understanding of cannabis therapeutics.

NIHR (National Institute for Health and Care Research) Trials

The NIHR operates as the research funding arm of the NHS and has become a central hub for commissioning and supporting cannabis-related clinical trials. The NIHR Portfolio includes multiple trials investigating cannabis treatments across different conditions. These trials undergo rigorous peer review and must meet stringent quality standards before receiving funding. The NIHR’s involvement ensures that participating sites maintain high ethical standards and provide robust data collection methodologies. Many NIHR-supported trials are conducted in NHS facilities across England, Scotland, Wales, and Northern Ireland, making them accessible to a broad patient population.

Drug Science Research

Drug Science, a UK-based charity founded by Professor David Nutt, has emerged as a leading independent research organisation conducting cannabis clinical trials. Their research focuses on real-world evidence and patient outcomes, often complementing traditional trial designs with naturalistic observation. Drug Science’s approach emphasises patient-centred research and has pioneered several important studies examining medical cannabis use in clinical practice. The organisation collaborates with NHS trusts and private clinical centres to deliver high-quality research outcomes.

NHS England Specialist Services

Several NHS England Specialist Commissioning services have established dedicated cannabis clinics that incorporate research components. These clinics provide both clinical care and research opportunities, allowing eligible patients to access medical cannabis whilst contributing to the evidence base. The NHS approach ensures that research is integrated within the broader healthcare system, making participation more accessible for patients already engaged with NHS services.

Key Research Areas and Conditions Under Investigation

Current medical cannabis clinical trials in the UK focus on several well-defined therapeutic areas where preliminary evidence suggests potential benefit:

Trial Designs and Methodological Approaches

Current UK trials employ diverse methodological approaches suited to the research questions being addressed. Many utilise randomised controlled trial (RCT) designs, considered the gold standard for establishing efficacy. Others employ pragmatic trial designs that reflect real-world clinical practice, acknowledging the challenges of standardised cannabis research. Open-label studies provide valuable safety and tolerability data, whilst longer-term observational studies track outcomes in patients receiving medical cannabis through established clinical pathways.

How to Join a Medical Cannabis Clinical Trial

Step-by-Step Process

• Identify Suitable Trials: Visit the NIHR Clinical Research Network Portfolio website (www.nihr.ac.uk) or the Drug Science website to search for active trials matching your condition. Use keywords specific to your diagnosis and location.
• Review Eligibility Criteria: Carefully examine inclusion and exclusion criteria for each trial. These typically specify age requirements, diagnosis confirmation methods, concomitant medication restrictions, and medical history factors that might affect participation.
• Contact Research Sites: Once you identify relevant trials, contact the trial’s principal investigator or research team at your nearest participating site. Contact details are typically provided on trial registration pages.
• Screening Appointment: If preliminary eligibility is confirmed, you’ll be invited for a screening assessment. This appointment involves detailed medical history, physical examination, baseline measurements, and discussion of trial procedures and potential risks.
• Informed Consent: Before enrolment, you must provide written informed consent after thorough discussion with the research team. This ensures you understand the trial’s nature, risks, benefits, and your rights as a participant.
• Baseline Assessment: Participants undergo comprehensive baseline testing, including symptom severity measurements, blood tests, and other condition-specific assessments.
• Trial Participation: Following baseline assessment, participants receive the assigned intervention (cannabis product or placebo) and attend scheduled follow-up visits for monitoring and outcome measurement.

Important Considerations for Potential Participants

• Participation is entirely voluntary and you may withdraw at any time without affecting your NHS care
• Trials typically exclude patients taking certain medications that interact with cannabinoids
• Pregnancy and breastfeeding generally preclude participation due to limited safety data
• Driving restrictions may apply during trial participation, depending on cannabis product and trial requirements
• Some trials offer financial compensation for time and travel expenses

Future Directions

The UK’s medical cannabis research programme continues expanding, with increasing numbers of trials launching each year. Future research directions include investigation of specific cannabinoid combinations, long-term safety and efficacy studies, and research into emerging therapeutic applications. As the evidence base strengthens, this research will increasingly inform clinical guidelines and NHS treatment pathways, potentially expanding access to medical cannabis for patients with appropriate conditions.

Medical cannabis clinical trials represent an important opportunity for eligible patients to access potentially beneficial treatments whilst contributing to scientific knowledge that advances therapeutic options for all patients.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Medical cannabis is a prescription-only medicine in the UK. Always consult a qualified healthcare professional. CannaZen is an information platform, not a medical provider.